Dramatic impact of morbid obesity on child lung development.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 04 10 2019
revised: 07 10 2020
accepted: 13 02 2021
pubmed: 15 3 2021
medline: 3 11 2021
entrez: 14 3 2021
Statut: ppublish

Résumé

To assess the respiratory function and sleep characteristics of obese adults and children. All patients with non-syndromic, severe obesity (BMI ≥3 z-scores for children and ≥40.00kg/m A total of 69 children (mean±SD BMI 36.8±6.7 and mean BMI z-score 4.7±1.0) and 70 adults were included (mean BMI 45.7±6.2). Metabolic syndrome was diagnosed in 13 children (26%) and 40 adults (80%). Reduced lung volumes were observed in 34 children (50.0%) and 16 adults (24.0%) and both the mean functional residual capacity (FRC) and the mean residual volume (RV) were lower in children than in adults (FRC: -1.7±2.1 z-score in children vs. -1.0±1.1 in adults, P=0.026; and RV: -0.8±1.2 z-score in children vs. -0.1±1.1 in adults, P=0.002). The prevalence of severe obstructive sleep apnea syndrome was greater in adults (40.7% vs. 18.8%, P=0.007). Children had a higher average oxygen saturation (median of 96.0% [91.0-98.0] vs. 93.0% [76.0-97.0] in adults, P<0.0001). Obesity has consequences for lung volumes in children; however, a longitudinal study is needed to determine the impact on pulmonary expansion and growth.

Identifiants

pubmed: 33714673
pii: S0929-693X(21)00033-6
doi: 10.1016/j.arcped.2021.02.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

186-190

Informations de copyright

Copyright © 2021 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

A Hochart (A)

Pediatric department, CHU of Lille, 59000 Lille, France. Electronic address: audrey.hochart@gmail.com.

V Nève (V)

University of Lille, CHU of Lille, EA4483, Pulmonary function test unit, 59000 Lille, France.

E Drumez (E)

Department of biostatistics, University of Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, 59000 Lille, France.

M Pigeyre (M)

Department of nutrition, University of Lille, CHU of Lille, Centre intégré d'obésité, 59000 Lille, France.

A Mallart (A)

Pulmonology department, CHU of Lille, 59000 Lille, France.

C Monaca (C)

Neurophysiology department, University of Lille, CHU of Lille, 59000 Lille, France.

O Le Rouzic (O)

Pneumology department, University of Lille, CHU of Lille, 59000 Lille, France.

I Gueorguieva (I)

Pediatric department, CHU of Lille, centre intégré d'obésité, 59000 Lille, France.

R Matran (R)

University of Lille, CHU of Lille, EA4483, Pulmonary function test unit, 59000 Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH